APA (7th ed.) Citation

Mouraux, A., Bloms-Funke, P., Boesl, I., Caspani, O., Chapman, S. C., Di Stefano, G., . . . Treede, R. (2021). IMI2-PainCare-BioPain-RCT3: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG). Trials, 22, . https://doi.org/10.1186/s13063-021-05272-y

Chicago Style (17th ed.) Citation

Mouraux, Andre, et al. "IMI2-PainCare-BioPain-RCT3: A Randomized, Double-blind, Placebo-controlled, Crossover, Multi-center Trial in Healthy Subjects to Investigate the Effects of Lacosamide, Pregabalin, and Tapentadol on Biomarkers of Pain Processing Observed by Electroencephalography (EEG)." Trials 22 (2021). https://doi.org/10.1186/s13063-021-05272-y.

MLA (9th ed.) Citation

Mouraux, Andre, et al. "IMI2-PainCare-BioPain-RCT3: A Randomized, Double-blind, Placebo-controlled, Crossover, Multi-center Trial in Healthy Subjects to Investigate the Effects of Lacosamide, Pregabalin, and Tapentadol on Biomarkers of Pain Processing Observed by Electroencephalography (EEG)." Trials, vol. 22, 2021, https://doi.org/10.1186/s13063-021-05272-y.